Large-cap Health Care company BioNTech SE has logged a 2.5% change today on a trading volume of 480,216. The average volume for the stock is 692,062.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. Based in Mainz, Germany the company has 5,500 full time employees and a market cap of $26,113,677,312.
The company is now trading -32.43% away from its average analyst target price of $160.36 per share. The 17 analysts following the stock have set target prices ranging from $107.36 to $258.46, and on average give BioNTech SE a rating of buy.
Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2022-12-31 | 17,310,600 | 9,434,400 | 54.5 | 0.48 |
2021-12-31 | 18,976,700 | 10,292,500 | 54.24 | 1621.9 |
2020-12-31 | 482,325 | 15,198 | 3.15 | 101.91 |
2019-12-31 | 108,589 | -179,056 | -164.89 | n/a |